scholarly journals SAT0252 The impact of rheumatoid arthritis on employment status and social network: a cross-sectional study of 146 patients

Author(s):  
LS Ines ◽  
P Reis ◽  
MJ Santos ◽  
M Alexandre ◽  
C Silva ◽  
...  
2013 ◽  
Vol 6 ◽  
pp. CMAMD.S11481 ◽  
Author(s):  
J Al-Bishri ◽  
SM Attar ◽  
Nawal Bassuni ◽  
Yasser Al-Nofaiey ◽  
Hamed Qutbuddeen ◽  
...  

Comorbid conditions play a pivotal role in rheumatoid arthritis management and outcomes. We estimated the percentage of comorbid illness among rheumatoid arthritis patients and explored the relationship between this comorbidity and different prescriptions. A cross-sectional study of patients with rheumatoid arthritis in three centers in Saudi Arabia was carried out. Comorbidity and antirheumatoid medication regimens prescribed were recorded on a specially designed Performa. The association between comorbidity and different drugs was analyzed. A total of 340 patients were included. The most comorbidities were hypertension 122 (35.9%), diabetes 105 (30.9%), osteoporosis 88 (25.8%), and dyslipidemia in 66 (19.4). The most common drug prescribed was prednisolone in 275 (80.8%) patients followed by methotrexate in 253 (74.4%) and biological therapy in 142 (41.5%) patients. Glucocorticoids were prescribed considerably more frequently in hypertensive and diabetic patients as well as in patients with osteoporosis and dyslipidemia. Most patients with rheumatoid arthritis suffered from comorbid diseases.


Rheumatology ◽  
2015 ◽  
Vol 54 (8) ◽  
pp. 1478-1487 ◽  
Author(s):  
Xiaoying Zhang ◽  
Rong Mu ◽  
Xiuru Wang ◽  
Chuanhui Xu ◽  
Tianjiao Duan ◽  
...  

BMJ Open ◽  
2017 ◽  
Vol 7 (4) ◽  
pp. e014698 ◽  
Author(s):  
Anna Sidorchuk ◽  
Karin Engström ◽  
Charisse M Johnson ◽  
Naima Kayser Leeoza ◽  
Jette Möller

Author(s):  
Khaled Algohani ◽  
Muhannad Althobaiti ◽  
Sanad Alshammari ◽  
Fahad Alnahari ◽  
Ali Aldahhasi ◽  
...  

2018 ◽  
Vol 31 (3) ◽  
Author(s):  
Jolanta Majer ◽  
Sandra Pyda ◽  
Jerzy Robert Ladny ◽  
Antonio Rodriguez-Nunez ◽  
Lukasz Szarpak

2018 ◽  
Vol 68 (12) ◽  
pp. 2987-2991
Author(s):  
Cristina Iordache ◽  
Bogdan Vascu ◽  
Eugen Ancuta ◽  
Rodica Chirieac ◽  
Cristina Pomirleanu ◽  
...  

Temporomandibular joint (TMJ) is commonly involved in various immune-mediated rheumatic disorders accounting for significant disability and impaired quality of life. The aim of our study was to assess inflammatory and immune parameters in patients with TMJ arthritis related to rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA) and to identify potential relation with severity and dysfunction of TMJ pathology. We performed a cross-sectional study in a cohort of 433 consecutive RA, 32 JIA, 258 AS, and 103 PsA. Only patients presenting with clinically significant TMJ involvement (273) related to their rheumatic condition were included in the final analysis. TMJ involvement is traditionally described in chronic inflammatory rheumatic disorders, particularly in patients with higher levels of inflammation as detected in rheumatoid arthritis and psoriatic arthritis. Disease activity and severity, as well as biological and positive serological assessments (rheumatoid factor, anti-cyclic citrullinated peptide, IL-1) remain significant determinants of the severity of TMJ arthritis.


Sign in / Sign up

Export Citation Format

Share Document